Replimune Group, Inc. REPL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

51/100

2/6 Pass

SharesGrow Intrinsic Value

Replimune Group, Inc. (REPL) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ASND, AVTE, CERE, CRNX, GOSS, KRON 等.

REPL 的市值为 $188.27M, 而同行平均市值为 $3.45B. REPL 显著小于其平均同行.

同行与相似公司 — REPL

ASND

Ascendis Pharma A/S

$241.71 -3.25% $14.84B

AVTE

Aerovate Therapeutics, Inc.

$2.68 0.00% $77.68M

CERE

Cerevel Therapeutics Holdings, Inc.

$44.96 +0.74% $8.19B

CRNX

Crinetics Pharmaceuticals, Inc.

$39.77 +0.05% $4.16B

GOSS

Gossamer Bio, Inc.

$0.46 +6.58% $107.96M

Keros Therapeutics, Inc.

$11.71 +1.39% $435.86M

KURA

Kura Oncology, Inc.

$9.05 -0.98% $799.38M

LYRA

Lyra Therapeutics, Inc.

$0.44 -11.98% $781.13K

MLYS

Mineralys Therapeutics, Inc.

$30.42 +11.35% $2.02B

NewAmsterdam Pharma Company N.V.

$34.01 -1.25% $3.91B

其他人也在看

UTHR

United Therapeutics Corporation

Cerevel Therapeutics Holdings, Inc.

Protagonist Therapeutics, Inc.

$105.44

+0.69%

CRNX

Crinetics Pharmaceuticals, Inc.

$39.77

+0.05%

NAMS

NewAmsterdam Pharma Company N.V.

$34.01

-1.25%

Replimune Group, Inc. REPL NASDAQ

同行与相似公司 — REPL

其他人也在看

获取低估股票提醒